ProPhase Labs, Inc. Comparables
Find the most relevant public market comparables for ProPhase Labs, Inc., including EV/Revenue and EV/EBITDA multiples to help you make informed investment decisions.
Company Overview
ProPhase Labs, Inc. is a next-generation biotech, genomics, and consumer products company focused on creating healthier lives through bold action and insightful innovation. They are revolutionizing healthcare with industry-leading whole genome sequencing solutions and developing diagnostics and therapeutics in the fight against cancer, including a potentially life-saving esophageal cancer test. They also develop, manufacture, and commercialize health and wellness solutions.
Business Model
ProPhase Labs operates through multiple segments including diagnostic services (offering whole genome sequencing and cancer diagnostics), and consumer products (developing and marketing over-the-counter health products and dietary supplements). The company is also exploring strategic options, including a potential sale of its subsidiary, Nebula Genomics.
Target Customers
Healthcare providers, consumers (direct-to-consumer marketing for dietary supplements), health plans, third-party payers, and government organizations (for diagnostic services).
Specific Focus
Whole genome sequencing, cancer diagnostics (especially esophageal cancer), and over-the-counter health and wellness products.
Location
Garden City, New York
CEO
Ted Karkus
Industry
Life sciences
Sub Sector
Biotechnology, Genomics, Diagnostics
3yr Revenue Growth
206%
Website
Public Market Comparables
Below are the key valuation metrics for companies similar to ProPhase Labs, Inc. in the Healthcare sector. These metrics can help you understand how the market values companies with similar business models and growth profiles.
Looking for a comprehensive compset for ProPhase Labs, Inc.? Our platform provides detailed analysis of ProPhase Labs, Inc.'s competitive landscape, including financial metrics, growth trends, and market positioning. Get access to the full ProPhase Labs, Inc. compset by trying our platform today.
EV/Revenue Multiple
Min
0.0x
Median
0.0x
Max
00.0x
Unlock actual values by trying our platform
View Full DetailsEV/EBITDA Multiple
Min
00.0x
Median
00.0x
Max
00.0x
Unlock actual values by trying our platform
View Full Details
Unlock the Full ProPhase Labs, Inc. Compset
As a leading player in the Life sciences industry within the Healthcare sector, ProPhase Labs, Inc. operates in the specialized Biotechnology, Genomics, Diagnostics sub-sector. Understanding how ProPhase Labs, Inc. compares to its public market comps is essential for accurate valuation and strategic decision-making.
Our comprehensive analysis includes detailed comparables (compsets) featuring similar companies in the Biotechnology, Genomics, Diagnostics space, with complete financial metrics, growth trajectories, and competitive positioning insights that go beyond the surface-level data shown above.
Other Interesting Companies
TG Therapeutics, Inc.
Healthcare • Life sciences
TG Therapeutics, Inc. is a fully integrated, commercial-stage biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. They have received FDA approval for BRIUMVI (ublituximab-xiiy) for the treatment of adult patients with relapsing forms of multiple sclerosis.
Vytalize Health
Healthcare • Life sciences
Vytalize Health is a risk-bearing provider enablement platform and leading Accountable Care Organization (ACO) that partners with primary care physicians (PCPs) to deliver value-based care, improving patient outcomes and reducing healthcare costs. They offer an all-in-one solution including value-based incentives, smart technology, and a virtual clinic, enabling independent practices to thrive in value-based care arrangements. The company focuses on Medicare patients and works with over 2,500 PCPs across 36 states.
Talkiatry
Healthcare • Life sciences
Talkiatry is a national mental health practice providing in-network psychiatry and therapy via telehealth. It utilizes technology and a human-centered approach to improve access to high-quality mental healthcare, addressing issues of accessibility and affordability.
Get Your Custom Comparable Analysis
Need a more detailed analysis of ProPhase Labs, Inc. and its public market comparables? Our platform provides comprehensive valuation metrics, growth analysis, and more.
Try CompsetFinder Free